On The Horizon – The Future of Anti-Obesity Medications (Recorded)

Recorded On: 10/14/2022


Back to Package

Over the last decade, the FDA has approved five new medications for the treatment of obesity. The latest edition, semaglutide, published impressive weight loss results and we are just beginning. There is a rich pipeline of future anti-obesity medications (AOM) that will give provides excellent options for both the treatment of obesity and of the obesity-related diseases. This session will start with reviewing some of the common pathophysiologic pathways that current and future AOM’s target then discuss emerging and future prospects of pharmacotherapy for the treatment of obesity.

Learning Objectives:

Identify pathophysiologic pathways targeted to treat obesity

Discuss emerging therapies for the medical treatment of obesity

Describe some novel obesity treatments under investigation

Discuss the role cardiovascular outcomes may play in the evaluation of AOM’s

Key:

Complete
Failed
Available
Locked
Speaker disclosure
Open to download resource.
Open to download resource.
Session Slides
Open to download resource.
Open to download resource.
Recorded Lecture
Open to view video.
Open to view video.
Quiz
1 Question  |  3 attempts  |  1/1 points to pass
1 Question  |  3 attempts  |  1/1 points to pass
Certificate
1.00 AMA PRA Category 1 Credit(s)™ credit  |  Certificate available
1.00 AMA PRA Category 1 Credit(s)™ credit  |  Certificate available